444 related articles for article (PubMed ID: 27904159)
1. Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis.
Xu Q; Tian Y; Peng H; Li H
Hypertens Res; 2017 May; 40(5):465-471. PubMed ID: 27904159
[TBL] [Abstract][Full Text] [Related]
2. Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study.
De Marchis GM; Weck A; Audebert H; Benik S; Foerch C; Buhl D; Schuetz P; Jung S; Seiler M; Morgenthaler NG; Mattle HP; Mueller B; Christ-Crain M; Arnold M; Katan M
Stroke; 2014 Oct; 45(10):2918-23. PubMed ID: 25169950
[TBL] [Abstract][Full Text] [Related]
3. Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study.
Greisenegger S; Segal HC; Burgess AI; Poole DL; Mehta Z; Rothwell PM
Stroke; 2015 Nov; 46(11):3117-23. PubMed ID: 26451023
[TBL] [Abstract][Full Text] [Related]
4. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes.
Wang CB; Zong M; Lu SQ; Tian Z
J Diabetes Complications; 2016; 30(8):1532-1536. PubMed ID: 27554438
[TBL] [Abstract][Full Text] [Related]
5. Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics.
Wendt M; Ebinger M; Kunz A; Rozanski M; Waldschmidt C; Weber JE; Winter B; Koch PM; Nolte CH; Hertel S; Ziera T; Audebert HJ;
Stroke; 2015 Sep; 46(9):2426-31. PubMed ID: 26251255
[TBL] [Abstract][Full Text] [Related]
6. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke.
Katan M; Fluri F; Morgenthaler NG; Schuetz P; Zweifel C; Bingisser R; Müller K; Meckel S; Gass A; Kappos L; Steck AJ; Engelter ST; Müller B; Christ-Crain M
Ann Neurol; 2009 Dec; 66(6):799-808. PubMed ID: 20035506
[TBL] [Abstract][Full Text] [Related]
7. Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: the CoRisk study.
De Marchis GM; Katan M; Weck A; Brekenfeld C; Mattle HP; Buhl D; Müller B; Christ-Crain M; Arnold M
Int J Stroke; 2013 Apr; 8(3):214-8. PubMed ID: 22336226
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of copeptin: one-year outcome in patients with acute stroke.
Urwyler SA; Schuetz P; Fluri F; Morgenthaler NG; Zweifel C; Bergmann A; Bingisser R; Kappos L; Steck A; Engelter S; Müller B; Christ-Crain M; Katan M
Stroke; 2010 Jul; 41(7):1564-7. PubMed ID: 20508186
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic and prognostic value of copeptin in patients with acute ischemic stroke and transient ischemic attack: A systematic review and meta-analysis.
Blek N; Szwed P; Putowska P; Nowicka A; Drela WL; Gasecka A; Ladny JR; Merza Y; Jaguszewski MJ; Szarpak L
Cardiol J; 2022; 29(4):610-618. PubMed ID: 35621091
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic role of resistin and copeptin in acute ischemic stroke.
Perovic E; Mrdjen A; Harapin M; Tesija Kuna A; Simundic AM
Top Stroke Rehabil; 2017 Dec; 24(8):614-618. PubMed ID: 28845746
[TBL] [Abstract][Full Text] [Related]
12. Plasma copeptin and long-term outcomes in acute ischemic stroke.
Zhang JL; Yin CH; Zhang Y; Zhao LB; Fu HJ; Feng JC
Acta Neurol Scand; 2013 Dec; 128(6):372-80. PubMed ID: 23614762
[TBL] [Abstract][Full Text] [Related]
13. The determination of copeptin levels helps management decisions among transient ischaemic attack patients.
Purroy F; Suárez-Luis I; Cambray S; Farré J; Benabdelhak I; Mauri-Capdevila G; Sanahuja J; Quílez A; Begué R; Gil MI; Molina-Seguin J; Torreguitart N
Acta Neurol Scand; 2016 Aug; 134(2):140-7. PubMed ID: 26471428
[TBL] [Abstract][Full Text] [Related]
14. Association of Level and Increase in D-Dimer With All-Cause Death and Poor Functional Outcome After Ischemic Stroke or Transient Ischemic Attack.
Hou H; Xiang X; Pan Y; Li H; Meng X; Wang Y
J Am Heart Assoc; 2021 Feb; 10(3):e018600. PubMed ID: 33412918
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of copeptin in patients with acute stroke.
Jiao L; Chu C; Zhou S
Expert Rev Neurother; 2015 May; 15(5):563-70. PubMed ID: 25865618
[TBL] [Abstract][Full Text] [Related]
16. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
De Marchis GM; Katan M; Weck A; Fluri F; Foerch C; Findling O; Schuetz P; Buhl D; El-Koussy M; Gensicke H; Seiler M; Morgenthaler N; Mattle HP; Mueller B; Christ-Crain M; Arnold M
Neurology; 2013 Apr; 80(14):1278-86. PubMed ID: 23468541
[TBL] [Abstract][Full Text] [Related]
17. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke.
Tu WJ; Ma GZ; Ni Y; Hu XS; Luo DZ; Zeng XW; Liu Q; Xu T; Yu L; Wu B
Neurology; 2017 May; 88(20):1899-1905. PubMed ID: 28424274
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of copeptin predict 1-year mortality in patients with acute ischemic stroke.
Wang CW; Wang JL; Zhang Y; Li Q; Guo SX; Ji SB
Neuroreport; 2014 Dec; 25(18):1447-52. PubMed ID: 25383462
[TBL] [Abstract][Full Text] [Related]
19. Serum Neurofilament Light Chain as a Predictive Biomarker for Ischemic Stroke Outcome: A Systematic Review and Meta-analysis.
Liu D; Chen J; Wang X; Xin J; Cao R; Liu Z
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104813. PubMed ID: 32305278
[TBL] [Abstract][Full Text] [Related]
20. Stress hormones predict cerebrovascular re-events after transient ischemic attacks.
Katan M; Nigro N; Fluri F; Schuetz P; Morgenthaler NG; Jax F; Meckel S; Gass A; Bingisser R; Steck A; Kappos L; Engelter S; Müller B; Christ-Crain M
Neurology; 2011 Feb; 76(6):563-6. PubMed ID: 21228295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
